FVF. Viveiros

F. Viveiros

*This is an algorithmically generated author record based on publicly available information.

F. Viveiros has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Aplicação tópica de mitomicina-C como adjuvante no tratamento broncoscópico da estenose traqueal pós-entubação

    by F. Viveiros, J. Gomes, A. Oliveira, S. Neves, J. Almeida, J. Moura e Sá

    Post-intubation tracheal stenosis (PITS) continues to be challenging in terms of diagnosis, management and prevention. Recurrence is common because of excessive granulation tissue formation and an insidious process of scar contracture. Topical application of mitomycin-C (MMC) as an adjuvant treatment for endoscopic management of stenosis has shown good results. The authors aimed to evaluate the results of MMC topical application following bronchoscopic dilatation as an adjuvant in PITS treatment. Retrospectively selected patients with PITS who had had rigid bronchoscopy (RB) dilatation followed by MMC application as adjuvant to endoscopic treatment. MMC in a concentration of 0.4 mg/ml was applied with a cotton stiletto around the stenotic lesion and granulation tissue for 3 minutes. Eleven patients with PITS, with a median initial tracheal stenosis of 75% of the lumen, underwent RB/MMC treatment. Mean MMC sessions performed/patient was 3.5, with good response and prolonged decrease in granulation tissue formation in 55% of cases, moderate in 18% and relapse in 27%. Mean stenosis improvement was 34%. Topical MMC application at 0.4 mg/ml concentration seems to be associated with good results as adjuvant in PITS management with decrease in granulation tissue and sustained improvement in lumen diameter.


  • Open Access

    Adesão ao rastreio e tratamento da tuberculose em doentes infetados com o vírus da imunodeficiência humana

    by F. Viveiros, M. Mota, P. Brinca, A. Carvalho, R. Duarte

    Este estudo teve por objetivo avaliar a adesão dos doentes VIH ao rastreio e tratamento da TB, identificando fatores determinantes para a não adesão. Foram revistos os registos clínicos de todos os doentes infetados pelo VIH, observados pela primeira vez numa Unidade de Doenças Infeciosas Portuguesa entre 2007 e 2010 (152 doentes). O rastreio incluía: inquérito de sintomas, telerradiografia torácica e TST/IGRA. Em 2008, foi estabelecido um protocolo com um Centro Diagnóstico Pneumológico, que permitia aos doentes escolher o local para serem rastreados (descentralização). O rastreio foi oferecido a todos os doentes, 69 (45,4%) aceitaram. Antes da implementação do protocolo de descentralização, de 78 doentes, 20 (25%) aceitaram ser rastreados. Após a descentralização, de 64, 49 doentes (76,6%) aderiram ao rastreio. A descentralização dos cuidados de saúde mostrou estar associada a uma maior adesão ao rastreio (p < 0,001); enquanto ter uma doença definidora de sida (p = 0,002) ou ter mais idade (p = 0,04) foram associados a uma menor adesão ao rastreio. O diagnóstico de TB infeção latente foi feito em 14 doentes e de TB ativa em 18; 14 casos de TB ativa foram diagnosticados posteriormente durante o seguimento em consulta hospitalar. Nos doentes com TB ativa estar em terapêutica HAART mostrou associação com a adesão ao tratamento da TB (p = 0,03). Nesta população, a melhoria no acesso aos cuidados de saúde foi importante na aceitação do rastreio de tuberculose. This study aims to evaluate compliance of HIV patients to TB screening and treatment, identifying determinants for non-compliance. We reviewed clinical records of all HIV infected patients first attended in a Portuguese-Infectious-Unit from 2007-2010 (152 patients). Screening included: symptom inquiry, chest x-ray, TST/IGRA. In 2008 a protocol was established with a TB outpatient clinic allowing patients to choose where to perform screening (decentralization). All patients were offered screening, 69 (45.4%) accepted. Before decentralization, out of 78 patients, 20 (25%) accepted screening. After decentralization, out of 64 patients, 49 (76.6%) accepted screening. Decentralization was associated with higher levels of acceptance (p < 0.001), having an AIDS-defining-disease (p = 0.002) and being older (p = 0.04) was associated with lower screening acceptance. LTBI was diagnosed in 14 and active-TB in 18 cases; 14 cases of active-TB were later diagnosed during hospital appointments. For active-TB, being on HAART was related with treatment adherence (p = 0.03). In this population, improving health care access was important for screening compliance.